, Tracking Stock Market Picks
Enter Symbol:
Icad Inc. (ICAD) [hlAlert]

up 19.24 %

Icad Inc. (ICAD) rated Buy with price target $6 by MDB Capital Group

Posted on: Friday,  Aug 1, 2008  9:25 AM ET by MDB Capital Group

MDB Capital Group rated Buy Icad Inc. (NASDAQ: ICAD) on 08/01/2008, when the stock price was $3.17. Since
then, Icad Inc. has gained 19.24% as of 11/24/2015's recent price of $3.78.
If you would have followed this MDB Capital Group's recommendation on ICAD, you would have gained 19.24% of your investment in 2671 days.

iCAD, Inc. (iCAD) is a provider of computer-aided detection system (CAD) solutions that enable radiologists and other healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier. CAD is performed as an adjunct to mammography screening. CAD is also reimbursable in the United States under federal and third party insurance programs. iCAD is also developing CAD solutions for use with virtual colonoscopy to improve the detection of colonic polyps while delivering improved workflow for the radiologists, and higher quality patient care. In July 2008, the Company acquired pharmaco-kinetic based CAD products that aid in the interpretation of contrast enhanced MRI images of the breast and prostate.

MDB Capital has strives to be the leading micro-cap research firm. Our focus is on companies between $40-$200MM in market capitalization that are not widely covered by other research firms. Our objective in following this sector is to provide our investors with idea that lead to above markets returns. MDB strives to provide insightful, independent and performance-oriented research. We strictly maintain a pure research environment, where solid research opinions are formed by our analysts' thorough evaluations, rather than influenced by investment banking relationships.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/1/2008 9:25 AM Buy
3.17 6.00
as of 12/24/2008
1 Week up  11.11 %
1 Month up  17.02 %
3 Months down  -12.69 %
1 YTD down  -2.65 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy